Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 2:42 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 1,285 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Model 2 Clear all

Conditions: Opioid Use Disorder, Opioid Withdrawal, Substance Use Disorders
Interventions: Ibogaine Hydrochloride, Extended-release naltrexone injection, 380 mg, Matching Oral Placebo, Matching Intramuscular Placebo, My-E-Health SENTINEL Digital Monitoring and Human-Gated Escalation Platform, Standardized Psychological Preparation, Integration and Recovery Support, Garmin-Enabled Longitudinal Wellness Monitoring; Drug · Device · Behavioral + 1 more
Lead sponsor: Clive Michelsen; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Basalt, Colorado

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: I2-ART, Usual care; Behavioral · Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Autism Spectrum Disorder
Interventions: Treatment as Usual, Early Social Interaction Mobile Coaching (ESI-MC); Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 15 Months to 20 Months
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 8
States / cities: Los Angeles, California • Tallahassee, Florida • Atlanta, Georgia + 5 more

Conditions: Alopecia Areata
Interventions: Ritlecitinib 100 mg, Ritlecitinib 50 mg, Placebo - 100 mg, Placebo - 50 mg; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 12 Years and older
Enrollment: 674 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 60
States / cities: Birmingham, Alabama • Hot Springs, Arkansas • Brea, California + 39 more

Conditions: Glaucoma
Interventions: Telephone and Print based intervention; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 312 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Metabolic Syndrome
Interventions: intravenous glucose tolerance test, testosterone, anastrozole, goserelin acetate implant, aerobic capacity (VO2 Max), MRI, muscle biopsy, measurement of resting metabolic rate (energy expenditure), Dual energy x-ray absorptiometry, Fasting oral glucose tolerance test; Procedure · Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 50 Years to 75 Years · Male only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 2
States / cities: Baltimore, Maryland • Boston, Massachusetts

Conditions: Schizophrenia, Schizoaffective Disorder, Major Depression
Interventions: Family Member Provider Outreach, Enhanced treatment as usual (e-TAU); Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 70 Years
Enrollment: 238 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: West Los Angeles, California • Baltimore, Maryland

Conditions: Resilience, HIV-1-infection, Stress, Psychological
Interventions: RISE+, Stress Reduction Control; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 50 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Intensive Care Unit Acquired Weakness (ICUAW)
Interventions: FES-Cycling, Standard Care; Device · Other
Lead sponsor: Associate Professor Sue Berney PhD, BPT; Other
Eligibility: 18 Years and older
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 2
States / cities: Baltimore, Maryland • Durham, North Carolina

Conditions: Obstructive Sleep Apnea (OSA)
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 6,501 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 3
States / cities: San Francisco, California • Portland, Oregon • Pittsburgh, Pennsylvania

Conditions: Hypochondriasis
Interventions: Fluoxetine, Cognitive Behavioral Therapy (CBT), Supportive Therapy, Placebo; Drug · Behavioral · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 2
States / cities: Boston, Massachusetts • New York, New York

Conditions: Prostate Cancer
Interventions: Bi-parametric MRI-based cascaded deep-learning AI algorithm; Device
Lead sponsor: University of Arkansas; Other
Eligibility: 40 Years and older · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Cancer
Interventions: Patient Navigation (PN) 2.0 Checklist, One-on-one Patient Navigation (PN); Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 21 Years and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Older Persons Interested in Improving Their Brain Health
Interventions: Treatment as Usual, Cogtrastim Model; Behavioral
Lead sponsor: Nova Southeastern University; Other
Eligibility: 50 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Fort Lauderdale, Florida

Conditions: Mental Health Issue, Teamwork
Interventions: Team-focused Implementation, Standard Implementation; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Tobacco Cessation, Tobacco Abstinence, Tobacco Use, Tobacco Use Cessation, Tobacco Dependence
Interventions: Nicotine Replacement Therapy (NRT), Wellness Coaching; Drug · Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Gingivitis
Interventions: 0.454% stannous fluoride, 0.76% sodium monofluorophosphate, 0.454% stannous fluoride AM and 0.76% sodium monofluorophosphate PM; Drug
Lead sponsor: Procter and Gamble; Industry
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Social Isolation
Interventions: CONNECTED, VET BEFRIENDING; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Avoidant/Restrictive Food Intake Disorder
Interventions: Family-based Treatment for ARFID, Manualized Non-Specific Usual Care for ARFID; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 6 Years to 12 Years
Enrollment: 285 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Bleeding
Interventions: 60mg edoxaban, 180mg edoxaban, 50 IU/kg Beriplex P/N, 25 IU/kg Beriplex P/N, 10 IU/kg Beriplex P/N; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Diet, Healthy, Diet Habit, Disease, Chronic, Health Behavior, Rural Health
Interventions: The UnProcessed Pantry Project (UP3); Behavioral
Lead sponsor: Montana State University; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Bozeman, Montana

Conditions: ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myeloid Leukemia), MDS (Myelodysplastic Syndrome)
Interventions: Not listed
Lead sponsor: Miltenyi Biomedicine GmbH; Industry
Eligibility: 1 Year to 66 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Any Condition in N73.0 Specified as Chronic
Interventions: Active self-management intervention, Attention control phone calls; Other
Lead sponsor: Washington State University; Other
Eligibility: 45 Years and older
Enrollment: 290 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Anorexia Nervosa
Interventions: Interoceptive Exposure Treatment (IE), Family-Based Treatment (FBT); Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 12 Years to 18 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder

Family Navigation to Improve ADHD Treatment Adherence for Minority Children

Effectiveness Trial of Mobile ESI for Toddlers With Autism Identified by Early Screening in Primary Care

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

Interactive Study to Increase Glaucoma Adherence to Treatment

Insulin Sensitivity in Men With the Metabolic Syndrome

The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness.

Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV

eStimCycle: Early Rehabilitation in Critical Care

Direct Referral for Apnea Monitoring

Treatment of Hypochondriasis With CBT and/or SSRI

AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions

Patient Navigation 2.0

A Comparison of Two Approaches to Developing Brain Health Programs

Team-Focused Implementation in Child Advocacy Centers

Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness

A Three Month Bleeding-Model Clinical Study

Increasing Veterans' Social Engagement and Connectedness

Confirming the Efficacy/Mechanism of Family Therapy for Children With Low Weight ARFID

A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation

The UnProcessed Pantry Project (UP3)

PRAISE-IR Versus CIBMTR Controls

Chronic Care Management for Adults at FQHCs

Interoceptive Exposure for Adolescents With Low Weight Eating Disorders